Delivery Order SPE2DB22D3501-SPE2DB25FWU14
- Not listed
- This contract award is a delivery order worth $5,696.14 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 28, 2023 and is a firm fixed price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Remifentanil 2 mg vials. The $4,848.64 firm-fixed-price contract has a completion date of September 15, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $4,389 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562290966 units of the drug remifentanil hydrochloride in 1 mg vials. As the prime contractor, Amerisourcebergen will deliver the ordered pharmaceutical products to a location in Conshohocken, Pennsylvania by September 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract provides for the delivery of 1 mg vials of the medication Remifentanil, with a potential value of $3,544.70 and a completion date of February 22, 2024. The contract is not a set-aside. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,000 to Amerisourcebergen Drug Corporation to supply 1 mg vials of the drug remifentanil. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 7th through August 8th, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were...
- This federal contract award is for the delivery of 2 mg vials of the drug remifentanil, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $2,909.03 fixed-price delivery order is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- The Defense Logistics Agency awarded a $9,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 2 mg vials of the opioid analgesic remifentanil. Performance will take place in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling the Defense Logistics Agency's requirement for this controlled pharmaceutical under an unstated...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 1 mg vials, a prescription pain medication. The contract has a ceiling value of $4,925.60 and is a firm fixed price, non-set-aside contract with a performance period ending on June 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $1,768 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,056 vials of the analgesic remifentanil. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 26, 2023, under an indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the U.S....
- This federal contract award is for the delivery of REMIFENTANIL 2 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025, with a ceiling value of $7,265.20. The contract is a firm fixed-price delivery order with a completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU14Delivery Order
The Defense Logistics Agency awarded a $2,055.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of August 11, 2025. This is a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/8/25 |